InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,650.00
(
0.05%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.30
(
-0.11%
)
Bitcoin
61,088.79
(
-0.59%
)
Post# of 29313
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

biotech_researcher

Send PM Follow Ignore
Followers 82
Posts 12433
Boards Moderated 0
Alias Born 07/25/2008

biotech_researcher

Re: DewDiligence post# 17503

Tuesday, 11/06/2018 7:38:59 AM

Tuesday, November 06, 2018 7:38:59 AM

Post# of 29313
NVO- I’ve followed NVO for a while looking for an entry point. The CEO of Lilly was just interviewed on CNBC and was excited about a compound that appears to be a direct competitor to Saxenda in the final stage of its phase 3 trial.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up